Login / Signup
Low bioavailability hinders drug discovery against COVID-19, guided by in silico docking.
Priyankar Dey
Published in:
British journal of pharmacology (2020)
Keyphrases
</>
drug discovery
coronavirus disease
sars cov
molecular dynamics simulations
molecular dynamics
molecular docking
protein protein
small molecule